Patent details

Basic Information

Publication number:

EP3383385

WO Application Number:

EP2016079511

Type:

European Patent Granted for NL

Status:

Patent in Force

Publication Title:

Title When Made Available For Viewing:

Reason Lapsed:

Application number:

EP16805792.5

WO Publication Number:

WO2017093443

EPO Publication Language:

English

SPC Number:

First Applicant Residence Country:

Sweden (SE)

Publications:

Dates

Filing date:

01/12/2016

Grant date:

29/07/2020

EP Publication Date:

10/10/2018

WO Publication Date:

08/06/2017

Claims Translations Received Date:

Claims Translation B1 Received Date:

23/10/2020

Claims Translation B2 Received Date:

12/10/2023

Claims Translation B3 Received Date:

Lapsed By Non Payment Annual Fee Date:

Renunciation Date:

NullificationDate:

Published:

Due To Cession Date:

Registration date:

29/07/2020

EP B1 Publication Date:

29/07/2020

EP B2 Publication Date:

06/09/2023

EP B3 Publication Date:

Description Translation B1 Received Date:

Description Translation B2 Received Date:

Description Translation B3 Received Date:

Expiration date:

30/11/2036

Lapsed By Expiration Date:

Patent Validated Date:

24/10/2023

Revocation Date:

Invalidity Date:

Response To Novelty Search Report Received:

Patent Granting Request:

Lapsed date:

Applicant/holder

From:

19/08/2024

 

 

 

Name:

Oncopeptides Innovation AB

Address:

Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)

Historical Applicant/holder

From:

19/08/2024

To:

19/08/2024

 

Name:

Oncopeptides AB

Address:

Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)

From:

29/07/2020

To:

19/08/2024

 

Name:

Oncopeptides AB

Address:

Västra Trädgårdsgatan 15, 111 53 Stockholm, Sweden (SE)

Agent

1

Name:

dr. R.C. van Duijvenbode c.s.

From:

23/10/2023

Address:

NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)

To:

2

Name:

ir. M.F.J.M. Ketelaars c.s.

From:

09/11/2020

Address:

NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)

To:

23/10/2023

Inventor

Name:

LINDBERG, Jakob

Address:

S-111 53 Stockholm, Sweden (SE)

Priority

Priority Patent Number:

201521217

Priority Date:

01/12/2015

Priority Country:

United Kingdom (GB)

Classification

IPC or IDT classification:

A61K 31/223; A61K 31/573;

Publication

Bulletin

1

Bulletin Heading:

CO

Journal edition number:

35/24

Publication date:

28/08/2024

Description:

Changes in the Netherlands Patent Register

2

Bulletin Heading:

EP5

Journal edition number:

43/23

Publication date:

25/10/2023

Description:

European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995

3

Bulletin Heading:

MED

Journal edition number:

36/23

Publication date:

06/09/2023

Description:

Other communications

4

Bulletin Heading:

EP4

Journal edition number:

36/23

Publication date:

06/09/2023

Description:

European patents granted in amended form for the Netherlands

5

Bulletin Heading:

VB1

Journal edition number:

22/21

Publication date:

02/06/2021

Description:

Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

6

Bulletin Heading:

EP3

Journal edition number:

47/20

Publication date:

18/11/2020

Description:

European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

7

Bulletin Heading:

EP2

Journal edition number:

31/20

Publication date:

31/07/2020

Description:

European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:

202336

Publication date:

06/09/2023

Description:

Patent maintained (B2 publication)

2

Issue number:

202122

Publication date:

02/06/2021

Description:

Opposition procedure started

3

Issue number:

202035

Publication date:

26/08/2020

Description:

Application number/publication number of the divisional application (Art. 76) changed

4

Issue number:

202031

Publication date:

29/07/2020

Description:

Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:

Owner

Deed Number:

RC202401510A

Date Registered:

19/08/2024

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

dr. R.C. van Duijvenbode c.s.

Journal Edition Number:

Text:

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Assignment

Deed Number:

RC202401510B

Date Registered:

19/08/2024

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

dr. R.C. van Duijvenbode c.s.

Journal Edition Number:

Text:

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Added Owner(s)

Name:

Oncopeptides Innovation AB

Address:

Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Annual Fee

Annual Fee(s) Due Date:

31/12/2025

Annual Fee Number:

10

Annual Fee Amount:

400 Euro

Last Annual Payment Date:

04/10/2024

Last Annual Fee Paid Number:

9

Last Annual Fee Paid Amount:

340 Euro

Payer:

Computer Patent Annuities Limited (CPA)

	Filing date	Document type	Document Description	Number of pages	File Type
	23/10/2023	Outgoing Correspondence	Letter no formal defects	1	PDF	/3/5/1/2/8/0800582153/docs/ep16805792.5_2_572519l271.pdf
	12/10/2023	Claims	First filed claims	2	PDF	/3/5/1/2/8/0800582153/docs/ep16805792.5_3_claims20231012074508014.pdf
	12/11/2020	Outgoing Correspondence	Letter no formal defects	1	PDF	/3/5/1/2/8/0800582153/docs/ep16805792.5_1_378192l271.pdf
	23/10/2020	Claims	First filed claims	2	PDF	/3/5/1/2/8/0800582153/docs/ep16805792.5_0_claims20201023081533558.pdf